BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35502108)

  • 21. Response to comment on: Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic - A case report.
    Kamath YS; George NM; Sarpangala S; Kulkarni C
    Indian J Ophthalmol; 2022 Jan; 70(1):344-345. PubMed ID: 34937288
    [No Abstract]   [Full Text] [Related]  

  • 22. Branch retinal vein occlusion after COVID-19.
    Nourinia R; Ghassempour M; Ahmadieh H; Abtahi SH
    J Fr Ophtalmol; 2021 Oct; 44(8):e441-e443. PubMed ID: 34325925
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to comment on: Nasal vein occlusion after COVID-19: A case report.
    Güven YZ; Akbalık T; Akay F
    Indian J Ophthalmol; 2023 Jun; 71(6):2618. PubMed ID: 37322709
    [No Abstract]   [Full Text] [Related]  

  • 24. Immediate reactions after mRNA SARS-CoV-2 vaccination.
    Jeimy S; Wong T; Song C
    CMAJ; 2021 Dec; 193(48):E1842. PubMed ID: 34772737
    [No Abstract]   [Full Text] [Related]  

  • 25. Retinal venous occlusion following COVID-19 vaccination: Report of a case after third dose and review of the literature.
    Dutta Majumder P; Prakash VJ
    Indian J Ophthalmol; 2022 Jun; 70(6):2191-2194. PubMed ID: 35648014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment on: Nasal vein occlusion after COVID-19: A case report.
    Panigrahi PK
    Indian J Ophthalmol; 2023 Jun; 71(6):2617-2618. PubMed ID: 37322707
    [No Abstract]   [Full Text] [Related]  

  • 27. Possible COVID-19 MRNA Vaccine-Induced Case of Unilateral Central Retinal Vein Occlusion.
    Takacs A; Ecsedy M; Nagy ZZ
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1145-1150. PubMed ID: 35914296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal vein occlusion following COVID-19 vaccination.
    Peters MC; Cheng SSH; Sharma A; Moloney TP
    Clin Exp Ophthalmol; 2022 May; 50(4):459-461. PubMed ID: 35113504
    [No Abstract]   [Full Text] [Related]  

  • 29. Retinal venous occlusion in a child following Corbevax COVID-19 vaccination.
    Nangia P; Prakash VJ; Dutta Majumder P
    Indian J Ophthalmol; 2022 Oct; 70(10):3713-3715. PubMed ID: 36190080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19.
    Rego Lorca D; Rouco Fernandez A; Jimenez Santos M; Saenz-Frances F; Burgos-Blasco B; Donate Lopez J
    Acta Ophthalmol; 2021 Nov; 99(7):e1246-e1248. PubMed ID: 33354904
    [No Abstract]   [Full Text] [Related]  

  • 31. Ocular occlusions in two cases of COVID-19.
    Kulkarni MS; Rajesh R; Shanmugam MP
    Indian J Ophthalmol; 2022 May; 70(5):1825-1827. PubMed ID: 35502085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity.
    Edgerley S; Jeimy S; Zhu R
    CMAJ; 2022 Jun; 194(23):E807-E811. PubMed ID: 35697371
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination.
    Hansbauer M; Fastantz E; Lutz J; Hasan A
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):502-503. PubMed ID: 35916561
    [No Abstract]   [Full Text] [Related]  

  • 34. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology.
    Walinjkar JA; Makhija SC; Sharma HR; Morekar SR; Natarajan S
    Indian J Ophthalmol; 2020 Nov; 68(11):2572-2574. PubMed ID: 33120696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 36. Comment on: mRNA SARS-CoV-2 vaccination in patients after allogeneic hematopoietic cell transplantation.
    Mungmunpuntipantip R; Wiwanitkti V
    Transpl Infect Dis; 2022 Jun; 24(3):e13839. PubMed ID: 35419913
    [No Abstract]   [Full Text] [Related]  

  • 37. Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination.
    Kreuter A; Lausch S; Burmann SN; Paschos A; Michalowitz AL
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e669-e672. PubMed ID: 35536636
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.
    Fornaro M; Venerito V; Iannone F; Cacciapaglia F
    J Rheumatol; 2022 Mar; 49(3):334-335. PubMed ID: 35033998
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data-Reply.
    Shaia JK; Shukla P; Singh RP
    JAMA Ophthalmol; 2023 Dec; 141(12):1177-1178. PubMed ID: 37943544
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.